Axios @axios
Anthem is "going to continue to evaluate" the data around Aduhelm, the controversial Alzheimer's drug, before making final insurance coverage decisions. https://t.co/OElr8zAFVf — PolitiTweet.org
Created
Wed Jul 21 22:00:00 +0000 2021
Likes
4
Retweets
1
Source
TweetDeck
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Anthem is "going to continue to evaluate" the data around Aduhelm, the controversial Alzheimer's drug, before making final insurance coverage decisions. https://t.co/OElr8zAFVf — PolitiTweet.org